EUCTR2020-001363-85-DK进行中（未招募）1 期
COVID-19 Prophylaxis with hydroxychloroquine, Vitamin D, and Zinc supplementation in Danish nursing home residents – a randomized controlled trial - COVID-19 PREVENTIO
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 206
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Nursing home residents
- •-= 65 years of age
- •-Able to give informed consent or consent by proxy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 206
排除标准
- •-Prior SARS-CoV-2 positive rtPCR test
- •-Terminal illness
- •-Current prescription of hydroxychloroquine or chloroquine
- •-Allergy to hydroxychloroquine or chloroquine
- •-Known to suffer from either of the following: Cardiomyopathy; G6PD deficiency; Retinopathy; Severe hearing -deficits; QT prolongation; Child Pugh Score = C; psoriasis, myasthenia gravis; dysregulated diabetes, eGFR < 20 ml/min
- •-Deemed unable to swallow oral tablets
- •-Intake of the following medication due to potential QT prolongation
- •oMacrolides, quinolones, voriconazole, psychotropics with high risk of QT prolongation, amiodarone, or methadone
- •Intake of the following medication due to potential interaction
研究者
相似试验
进行中（未招募）
1 期
Prophylaxis of COVID-19 infection with hydroxychloroquine in healthcarepersonnel with high risk of infection.COVID-19 infectionEUCTR2020-001536-98-ESHOSPITAL UNIVERSITARI MÚTUA TERRASSA300
招募中
2 期
COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers: The COVID-SHIELD TrialCOVID-19 infectionInfection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12620000501943Walter and Eliza Hall Institute of Medical Research650
暂停
不适用
HYDROXYCHLOROQUINE TO PREVENT SARS-COV-2 INFECTIOPER-011-20IVERSIDAD PERUANA CAYETANO HEREDIA,42
进行中（未招募）
1 期
Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study (COPCOV)Profliaxis of SARS-CoV-2 infectionMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862EUCTR2020-001441-39-ITIVERSITY OF OXFORD40,000
进行中（未招募）
1 期
Chloroquine/ hydroxychloroquine prevention of COVID-19 (COPCOV)EUCTR2020-001441-39-GBniversity of Oxford10,000